1 unchanged sentence
Trading Arrangements
−Removed: During the three months ended June 30, 2024, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.
+Added: During the three months ended September 30, 2024, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.
Reference is made to the Index to Exhibits included herein.
51 unchanged sentences
(Filed as an exhibit to Form 8-K on May 22, 2014 and incorporated herein by reference.)
−Removed: 4.20 Officers’ Certificate of Amgen Inc., dated May 22, 2014, including form of the Company’s 3.625% Senior Notes due 2024.
−Removed: (Filed as an exhibit to Form 8-K on May 22, 2014 and incorporated herein by reference.)
4.20 Officer’s Certificate of Amgen Inc., dated May 1, 2015, including forms of the Company’s 3.125% Senior Notes due 2025 and 4.400% Senior Notes due 2045.
29 unchanged sentences
Second Amended and Restated 2009 Equity Incentive Plan.
−Removed: (As Amended and Restated on May 31, 2024.)
+Added: (As Amended and Restated on May 31, 2024.) (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2024 on August 7, 2024 and incorporated herein by reference.)
Form of Restricted Stock Unit Agreement for the Amgen Inc.
Second Amended and Restated 2009 Equity Incentive Plan.
−Removed: (As Amended and Restated on May 31, 2024.)
−Removed: 10.4+* Amgen Inc.
+Added: (As Amended and Restated on May 31, 2024.) (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2024 on August 7, 2024 and incorporated herein by reference.)
2009 Performance Award Program.
−Removed: (As Amended and Restated on May 31, 2024.)
+Added: (As Amended and Restated on May 31, 2024.) (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2024 on August 7, 2024 and incorporated herein by reference.)
Form of Performance Unit Agreement for the Amgen Inc.
2009 Performance Award Program.
−Removed: (As Amended and Restated on May 31, 2024.)
−Removed: 10.6+* Amgen Inc.
+Added: (As Amended and Restated on May 31, 2024.) (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2024 on August 7, 2024 and incorporated herein by reference.)
2009 Director Equity Incentive Program.
−Removed: (As Amended and Restated on May 31, 2024.)
+Added: (As Amended and Restated on May 31, 2024.) (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2024 on August 7, 2024 and incorporated herein by reference.)
Form of Restricted Stock Unit Agreement for the Amgen Inc.
2009 Director Equity Incentive Program.
−Removed: (As Amended and Restated on May 31, 2024.)
+Added: (As Amended and Restated on May 31, 2024.) (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2024 on August 7, 2024 and incorporated herein by reference.)
Form of Cash-Settled Restricted Stock Unit Agreement for the Amgen Inc.
2009 Director Equity Incentive Program.
−Removed: (As Amended and Restated on May 31, 2024.)
+Added: (As Amended and Restated on May 31, 2024.) (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2024 on August 7, 2024 and incorporated herein by reference.)
10.9+ Amgen Inc.
115 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: August 6, 2024 By:
+Added: October 30, 2024 By:
/ S / PETER H.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.